Table of Contents
Metal-Based Drugs
Volume 7, Issue 5, Pages 245-251
http://dx.doi.org/10.1155/MBD.2000.245

High In-Vitro Antitumour Activity of Triphenyltin Coumarin 3-Carboxylate and its Coordination Complexes With Monodentate Oxygen Donor Ligands Against the Epstein Barr Virus (EBV)-DNA Positive Raji and the P-388 Murine Leukaemia Cell Lines, and Evidence for the Suppression by Organotin of the Early Antigen Complex in the EBV Lytic Cycle

1Institute for Postgraduate Studies and Research, University of Malaya, Kuala Lumpur 50603, Malaysia
2Department of Chemistry, University of Malaya, Kuala Lumpur 50603, Malaysia
3Department of Biochemistry, University of Malaya, Kuala Lumpur 50603, Malaysia
4Institute of Biological Sciences, University of Malaya, Kuala Lumpur 50603, Malaysia

Received 31 October 2000; Accepted 28 November 2000

Copyright © 2000 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Joyce Koshy, V. G. Kumar Das, S. Balabaskaran, S. W. Ng, and Norhanom Wahab, “High In-Vitro Antitumour Activity of Triphenyltin Coumarin 3-Carboxylate and its Coordination Complexes With Monodentate Oxygen Donor Ligands Against the Epstein Barr Virus (EBV)-DNA Positive Raji and the P-388 Murine Leukaemia Cell Lines, and Evidence for the Suppression by Organotin of the Early Antigen Complex in the EBV Lytic Cycle,” Metal-Based Drugs, vol. 7, no. 5, pp. 245-251, 2000. https://doi.org/10.1155/MBD.2000.245.